Tag Archives: anti-obesity medication

Blaming a person for their weight is about as helpful as blaming them for their height. While science has shown that obesity is a disease largely driven by biology, many people living with obesity continue to be blamed for their weight by others, or worse, blame themselves for their weight. Studies have shown that obesity […]

Today the FDA approved semaglutide 2.4 mg weekly injection for chronic weight management. The brand name will be Wegovy™.* The molecule semaglutide has been used for the treatment of type II diabetes for the past 5 years at doses of up to 1 mg. Novo Nordisk is also seeking an approval for a 2 mg […]

Just published in the New England Journal, as part of a weight loss program, the addition of semaglutide helped people with obesity lose an average of 15% of their body weight during 68 weeks of treatment. This equated to an average of 34 pounds of weight loss during the trial. Heart Safety of Semaglutide As […]

Saxenda is the newest medication approved by the FDA for chronic weight management. Unlike the other medications which are taken as pills or capsules, Saxenda is a once daily self-administered injection. Originally marketed as Victoza for the treatment of type 2 diabetes back in 2010, Saxenda is the same molecule (liraglutide), but underwent rigorous clinical […]

Contrave is one of our new anti-obesity medications, or “AOMs” approved for chronic weight management in 2014. As the years have gone by, we have accumulated a lot of clinical experience with Contrave for weight loss. This article will review some of the pros and cons of Contrave use, particularly in comparison to the older […]